|
|
|
|
| LEADER |
00000cam a2200000Ma 4500 |
| 001 |
SCIDIR_ocn961344734 |
| 003 |
OCoLC |
| 005 |
20231120112149.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
161028s2016 ne o 001 0 eng d |
| 040 |
|
|
|a IDEBK
|b eng
|e pn
|c IDEBK
|d OPELS
|d YDX
|d OCLCQ
|d OCLCF
|d UPM
|d OTZ
|d OCLCQ
|d D6H
|d CNCGM
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 961828771
|a 964585658
|
| 020 |
|
|
|a 044463889X
|q (electronic bk.)
|
| 020 |
|
|
|a 9780444638892
|q (electronic bk.)
|
| 020 |
|
|
|z 9780444637185
|q (print)
|
| 020 |
|
|
|z 044463407X
|
| 020 |
|
|
|z 044463391X
|
| 020 |
|
|
|z 1322465312
|
| 020 |
|
|
|z 0444637184
|
| 035 |
|
|
|a (OCoLC)961344734
|z (OCoLC)961828771
|z (OCoLC)964585658
|
| 050 |
|
4 |
|a RM302.5
|
| 082 |
0 |
4 |
|a 615.7/042
|2 23
|
| 245 |
0 |
0 |
|a Side effects of drugs annual /
|c edited by Sidhartha D. Ray.
|
| 260 |
|
|
|a Amsterdam, Netherlands :
|b Elsevier,
|c �2016.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes indexes.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover; Side Effects of Drugs Annual: A worldwide yearly survey of new data in adverse drug reactions; Copyright; Contributors; Contents; Preface; Special Reviews in SEDA 38; Table of Essays, Annuals 1-37; Abbreviations; ADRs, ADEs and SEDs: A Bird's Eye View; Introduction; Analysis of ADEs, ADRs, Side Effects and Toxicity; Terminology; EIDOS; DoTS; WHO Classification; References on Adverse Drug Reactions; Pharmacogenomic Considerations; Introduction; Definition of Pharmacogenomics; References on Pharmacogenomic Considerations; Immunological Reactions.
|
| 505 |
8 |
|
|a Type I Reactions (IgE-Mediated Anaphylaxis Immediate Hypersensitivity); Type II Reactions (Cytotoxic Reactions); Type III Reactions (Immune Complex Reactions); Type IV Reactions (Cell-Mediated or Delayed Hypersensitivity Reactions); Other Types of Reactions; References; Analysis of Toxicological Reactions; Potentiation Reactions; Synergistic Effect; Additive Effect; Antagonistic Effects; References; Grades of Adverse Drug Reactions; References; FDA Pregnancy Categories/Classification of Teratogenicity; References; Conclusion.
|
| 505 |
8 |
|
|a Chapter 1: Central Nervous System Stimulants and Drugs That Suppress Appetite Amphetamine and Amphetamine Derivates [SEDA-34, 1; SEDA-35, 1; SEDA 36, 1; SEDA 37, 1]; Studies; Ecstasy (3,4-Methylenedioxy-N-Methylamphetamine; MDMA); Studies; Methylphenidate [SEDA-34, 5; SEDA-35, 1; SEDA-36, 1; SEDA-37, 1]; Studies; Methylxanthines; Caffeine [SEDA-15, 588; SEDA-32, 14; SEDA-33, 11; SEDA-34, 6; SEDA-36, 1; SEDA-37, 1]; Studies; Selective Norepinephrine Reuptake Inhibitors Atomoxetine [SEDA-34, 4; SEDA-36, 1; SEDA-37, 1]; Studies; Vigilance Promoting Drugs.
|
| 505 |
8 |
|
|a Modafinil and Armodafinil [SEDA-34, 6 SEDA-36, 1; SEDA-37, 1]; Studies; Drugs That Suppress Appetite [SEDA-34, 8; SEDA-36, 1; SEDA-37, 1]; Lorcaserin [SEDA-37, 1]; Phentermine [SEDA-34, 8; SEDA-36, 1; SEDA-37, 1]; Phentermine/Topiramate Extended Release (XR) [SEDA-37, 1]; Studies; Parasympathomimetics [SEDA-34, 9; SEDA-36, 1; SEDA-37, 1]; Rivastigmine [SEDA-34, 10; SEDA-36, 1; SEDA-37, 1]; Studies; Donepezil [SEDA-34, 10; SEDA-36, 1; SEDA-37, 1]; Studies; Galantamine [SEDA-36, 1; SEDA-37, 1]; Studies; References; Chapter 2: Antidepressant Drugs; General; Hematological.
|
| 505 |
8 |
|
|a Gastrointestinal Bleeding Intracranial Hemorrhage; Postpartum Hemorrhage; Reproductive System (Pregnancy, Development and Infancy); Spontaneous Abortion/Miscarriage; Teratogenesis-Cardiac Malformations; Persistent Pulmonary Hypertension of the Newborn (PPHN); Autism; Bone Density, Fracture Risk and Falls; Suicide/Self-Harm; Stroke; Selective Serotonin Re-Uptake Inhibitors (SSRIs) [SED-15, 3109; SEDA-31, 18; SEDA-32, 33; SEDA-33, 26; SEDA-34, 17; SEDA-35 ...; Citalopram and Escitalopram; Dystonia; Serotonin and Noradrenaline Re-Uptake Inhibitors (SNRIS); Venlafaxine and Desvenlafaxine [SED-15, 3614.
|
| 650 |
|
0 |
|a Drugs
|x Side effects.
|
| 650 |
|
2 |
|a Drug-Related Side Effects and Adverse Reactions
|0 (DNLM)D064420
|
| 650 |
|
6 |
|a M�edicaments
|x Effets secondaires.
|0 (CaQQLa)201-0002241
|
| 650 |
|
7 |
|a Drugs
|x Side effects
|2 fast
|0 (OCoLC)fst00898912
|
| 700 |
1 |
|
|a Ray, Sidhartha D.
|
| 776 |
0 |
8 |
|i Print version:
|t Side effects of drugs annual.
|d Amsterdam, Netherlands : Elsevier, �2016
|z 0444637184
|z 9780444637185
|w (OCoLC)952647370
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/03786080/38
|z Texto completo
|
